Product Images Gabapentin

This is a chart showing the mean pain score over a period of 4 weeks, divided into a dose titration period and a fixed dose period. The chart includes data for a placebo group and a group taking Gabapentin at a dosage of 3600 mg/day. The pain scores range from 0 to 10 and are plotted over a period of 4 weeks. No other information or context is available.*

This text describes a medical study with a 4-week dose titration period followed by a fixed dose period, comparing the effect of two different doses of gabapentin (1800mg/day and 2400mg/day) versus a placebo on pain scores over a six-week period. The results are presented in a table showing mean pain scores at baseline and weeks 1 through 5.*

This appears to be a figure from a study on the effectiveness of different treatments for post-herpetic neuralgia (PHN). The figure shows the proportion of responders (patients with >50% reduction in pain score) at endpoint for controlled PHN studies. The treatments shown include Gabapentin 3600 and 1800, and a placebo. The figure also includes p-values for statistical significance.*

Gabapentin Capsules containing 300mg of Gabapentin, USP. Keep out of reach of children and store at 20-25°C. May cause dizziness. This drug is available by prescription only and comes in a pack of 30 capsules. NDC number is 71335-1997-01.*

This is a prescription medicine packaging information that includes the name of the medicine (Neurontin 300mg Capsule), the manufacturer (Granules India Limited), the quantity (#30 EXP MM/YY), the NDC number (7133519971), and the recommended storage conditions (store at room temp of 20°-25°C or 68°-77°F). It also includes a cautionary statement to keep all drugs out of the reach of children.*